Reco analystes EyePoint, Inc.

Actions

EYPT

US30233G2093

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/07/2026			Varia. 5j.	Varia. 1 janv.
13,98 ^USD	+5,95 %		+1,97 %	-23,48 %

01/07	EYEPOINT, INC. : Chardan Research à l'achat	ZM
09/06	Transcript : EyePoint, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11:20 AM

Reco analystes

01/07	EYEPOINT, INC. : Chardan Research à l'achat	ZM
07/05	EYEPOINT, INC. : RBC Capital Markets toujours positif	ZM
05/03	EYEPOINT, INC. : Chardan Research favorable sur le dossier	ZM
06/11	EYEPOINT PHARMACEUTICALS, INC. : RBC Capital Markets toujours à l'achat	ZM
14/08/25	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities optimiste sur le dossier	ZM
17/06/25	EYEPOINT PHARMACEUTICALS, INC. : RBC Capital Markets passe de neutre à achat	ZM
16/05/25	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities reste à l'achat	ZM
07/01/25	EYEPOINT PHARMACEUTICALS, INC. : Citigroup revoit son opinion à la hausse	ZM
16/10/24	EYEPOINT PHARMACEUTICALS, INC. : Scotiabank favorable au dossier	ZM
04/06/24	EYEPOINT PHARMACEUTICALS, INC. : Opinion positive de JPMorgan Chase	ZM
08/05/24	EYEPOINT PHARMACEUTICALS, INC. : Baird persiste à l'achat	ZM
07/05/24	EYEPOINT PHARMACEUTICALS, INC. : Opinion positive de Chardan Research	ZM
07/05/24	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities toujours à l'achat	ZM
15/02/24	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities toujours à l'achat	ZM
22/01/24	EYEPOINT PHARMACEUTICALS, INC. : JPMorgan Chase persiste à l'achat	ZM
11/12/23	EYEPOINT PHARMACEUTICALS, INC. : Capital One Securities reste à l'achat	ZM
07/12/23	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities reste à l'achat	ZM
02/11/23	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright favorable sur le dossier	ZM
02/11/23	EYEPOINT PHARMACEUTICALS, INC. : Mizuho Securities persiste à l'achat	ZM
14/06/23	EYEPOINT PHARMACEUTICALS, INC. : JonesTrading Institutional Services réajuste son opinion à la hausse	ZM
19/05/23	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright à l'achat	ZM
19/05/23	EYEPOINT PHARMACEUTICALS, INC. : Chardan Research favorable sur le dossier	ZM
11/11/22	EYEPOINT PHARMACEUTICALS, INC. : Guggenheim toujours à l'achat	ZM
04/08/22	EYEPOINT PHARMACEUTICALS, INC. : HC Wainwright toujours à l'achat	ZM
07/07/22	EYEPOINT PHARMACEUTICALS, INC. : Chardan Research réitère son opinion positive sur le titre	ZM